SABS (STOCKS)
SAB Biotherapeutics, Inc. Common Stock
$3.750000
-0.050000 (-1.32%)
Prev close: $3.800000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Samuel J. Reich
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $341.19M
- Employees
- 63
- P/E (TTM)
- -2.29
- P/B (TTM)
- 1.48
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
7
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.28 | $-0.30 | +0.0152 | +5.15% |
|
Mar 2026 (Q1)
|
$-0.35 | $-0.23 | -0.1171 | -50.28% |
|
Dec 2025 (Q4)
|
$-0.35 | $-0.20 | -0.1473 | -72.67% |
|
Sep 2025 (Q3)
|
$-0.15 | $-0.52 | +0.3661 | +70.94% |